These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10554047)

  • 1. Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.
    Nishino S; Mignot E
    Clin Pharmacokinet; 1999 Oct; 37(4):305-30. PubMed ID: 10554047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL
    Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
    Spadoni G; Bedini A; Lucarini S; Mor M; Rivara S
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zolpidem for insomnia.
    Greenblatt DJ; Roth T
    Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFNS guidelines on management of narcolepsy.
    Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
    Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insomnia: assessment and management in primary care. National Heart, Lung, and Blood Institute Working Group on Insomnia.
    Am Fam Physician; 1999 Jun; 59(11):3029-38. PubMed ID: 10392587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep disturbances in the elderly residing in assisted living: findings from the Maryland Assisted Living Study.
    Rao V; Spiro JR; Samus QM; Rosenblatt A; Steele C; Baker A; Harper M; Brandt J; Mayer L; Rabins PV; Lyketsos CG
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):956-66. PubMed ID: 16163747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment of insomnia].
    Wichniak A; Murawiec S; Jernajczyk W
    Psychiatr Pol; 2006; 40(3):563-77. PubMed ID: 17037820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of chronic insomnia.
    Mendelson WB
    Sleep; 1995 Oct; 18(8):698-701. PubMed ID: 8560137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency and distribution of sleep problems and insomnia in the adult population in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].
    Schlack R; Hapke U; Maske U; Busch M; Cohrs S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 May; 56(5-6):740-8. PubMed ID: 23703493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of insomnia in community-dwelling Chinese elderly: a Taiwanese urban area survey.
    Su TP; Huang SR; Chou P
    Aust N Z J Psychiatry; 2004 Sep; 38(9):706-13. PubMed ID: 15324335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between psychiatric diseases and insomnia.
    Roth T
    Int J Clin Pract Suppl; 2001 Jan; (116):3-8. PubMed ID: 11219330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA-approved drugs to treat sleep disorders.
    J Psychosoc Nurs Ment Health Serv; 2012 Oct; 50(10):9-10. PubMed ID: 23053622
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insomnia. Diagnosis and management.
    Grunstein R
    Aust Fam Physician; 2002 Nov; 31(11):995-1000. PubMed ID: 12471955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of excessive daytime sleepiness].
    Sonka K
    Ceska Slov Psychiatr; 1996 May; 92 Suppl 1():15-22. PubMed ID: 8768941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.